HIV-1 Vpu complements HLA-A downregulation by Nef and impairs TCR-mediated recognition of HIV-infected cells through distinct mechanisms

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Many viruses, including HIV-1, target the human leukocyte antigen (HLA) class I molecules HLA-A, HLA-B, and HLA-C to evade immune surveillance. HIV-1 Nef selectively downregulates HLA-A and HLA-B, whereas Vpu variants from primary strains reduce cell-surface HLA-C expression. Whether HIV-1 also uses Vpu to target other HLA molecules has remained unclear. Here, we show that Vpu from primary strains reduces HLA-A, including the globally prevalent HLA-A2, on infected cells. Although Nef is the principal modulator of these molecules, Vpu acts independently of Nef and impairs TCR-mediated recognition of infected cells in co-culture systems. However, the reduction in TCR signaling is also dependent on the presence of BST2/tetherin, a restriction factor that retains nascent virions and targets them for degradation. HLA-A2-restricted, HIV-specific CTL responses were lowest when both Nef and Vpu were present. Vpu variants from chronic and transmitted/founder strains, but not from the prototypical recombinant strain NL4.3, were sufficient to reduce cell-surface HLA-A2, although activity varied widely among variants and appears to have arisen independently in different hosts. Coimmunoprecipitation and immunofluorescence analyses showed that Vpu interacts with HLA-A2 and redirects it to a perinuclear compartment which is probably the trans -Golgi network through a mechanism governed by the Vpu N-terminus/transmembrane domain. Overall, our findings reveal a previously unrecognized function of Vpu and show how HIV-1 uses Nef and Vpu to limit HLA-A-mediated viral antigen presentation and promote immune evasion.

IMPORTANCE

We show that the HIV-1 accessory protein Vpu, like Nef, downmodulates HLA-A on infected cells. Because Vpu also downmodulates HLA-C, it can substantially reduce overall HLA class I abundance and, consequently, viral antigen presentation to cytotoxic T lymphocytes (CTLs). Vpu impairs TCR-mediated recognition of infected cells through two distinct mechanisms: HLA-A2 downregulation and reduced virion retention through antagonism of the restriction factor BST2. CTL responses were most diminished when both Nef and Vpu were present, supporting a role for Vpu in evading T cell-mediated immunity. The ability of Vpu proteins from primary HIV-1 strains across clades and groups but not from the prototypical recombinant strain NL4.3 to reduce HLA-A2 levels suggests that HIV-1 evolved an additional mechanism to evade immune recognition and control.

Article activity feed

  1. HIV-1 Vpu complements HLA-A downregulation by Nef and impairs TCR-mediated recognition of HIV-infected cells through distinct mechanisms https://www.biorxiv.org/content/10.64898/2026.11.04.764327v1

  2. HIV-1 Vpu complements HLA-A downregulation by Nef and impairs TCR-mediated recognition of HIV-infected cells through distinct mechanisms https://www.biorxiv.org/content/10.64898/2026.11.04.764327v1